Investment
Features
FeesSafety
Academy
More
Pluang+

DexCom expects CONNECT study on type 2 diabetes to be published soon in a major journal.

Market News
09 Sep 2026
Seeking Alpha
View Source
Bullish
DexCom expects CONNECT study on type 2 diabetes to be published soon in a major journal.

At the 2026 Wells Fargo Healthcare Conference, DexCom's CFO Jereme Sylvain discussed the positive results from the CONNECT study on type 2 non-insulin diabetes. The company is preparing multiple filings related to CONNECT and conducting follow-up studies. They anticipate the study will be published soon in a major medical journal, although the exact timing and journal name are not disclosed due to publication protocols. This publication could enhance DexCom's profile in diabetes care innovation.

More News (DXCM)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App